| Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies EF Borba, E Bonfa Lupus 6 (6), 533-539, 1997 | 359 | 1997 |
| Circulating follicular helper–like T cells in systemic lupus erythematosus: association with disease activity JY Choi, JH Ho, SG Pasoto, V Bunin, ST Kim, S Carrasco, EF Borba, ... Arthritis & rheumatology 67 (4), 988-999, 2015 | 299 | 2015 |
| Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy. EF Borba, E Bonfá The Journal of rheumatology 28 (4), 780-785, 2001 | 220 | 2001 |
| Antimalarial treatment may have a time‐dependent effect on lupus survival: data from a multinational Latin American inception cohort SK Shinjo, E Bonfá, D Wojdyla, EF Borba, LA Ramirez, HR Scherbarth, ... Arthritis & rheumatism 62 (3), 855-862, 2010 | 208 | 2010 |
| Chylomicron metabolism is markedly altered in systemic lupus erythematosus EF Borba, E Bonfá, CGC Vinagre, JAF Ramires, RC Maranhão Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 184 | 2000 |
| Major depressive disorder and disease activity in systemic lupus erythematosus FG Nery, EF Borba, JP Hatch, JC Soares, E Bonfá, FL Neto Comprehensive psychiatry 48 (1), 14-19, 2007 | 180 | 2007 |
| Consenso de lúpus eritematoso sistêmico EF Borba, LC Latorre, JCT Brenol, C Kayser, NA Silva, AF Zimmermann, ... Revista Brasileira de Reumatologia 48, 196-207, 2008 | 175 | 2008 |
| First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano … BA Pons-Estel, E Bonfa, ER Soriano, MH Cardiel, A Izcovich, F Popoff, ... Annals of the rheumatic diseases 77 (11), 1549-1557, 2018 | 152 | 2018 |
| Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect E Cairoli, M Rebella, N Danese, V Garra, EF Borba Lupus 21 (11), 1178-1182, 2012 | 149 | 2012 |
| Lipoprotein (a) levels in systemic lupus erythematosus. EF Borba, RD Santos, E Bonfa, CG Vinagre, FJ Pileggi, W Cossermelli, ... The Journal of rheumatology 21 (2), 220-223, 1994 | 141 | 1994 |
| Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus KAM Kuruma, EF Borba, MH Lopes, JF De Carvalho, E Bonfa Lupus 16 (5), 350-354, 2007 | 130 | 2007 |
| Gonad evaluation in male systemic lupus erythematosus PMF Soares, EF Borba, E Bonfa, J Hallak, AL Corrêa, CAA Silva Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 128 | 2007 |
| Anti–lipoprotein lipase antibodies: A new player in the complex atherosclerotic process in systemic lupus erythematosus? JF de Carvalho, EF Borba, VST Viana, C Bueno, EP Leon, E Bonfá Arthritis & Rheumatism 50 (11), 3610-3615, 2004 | 128 | 2004 |
| Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL) MF Ugarte-Gil, D Wojdyla, GJ Pons-Estel, LJ Catoggio, C Drenkard, ... Annals of the rheumatic diseases 76 (12), 2071-2074, 2017 | 126 | 2017 |
| Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies FG Nery, EF Borba, VST Viana, JP Hatch, JC Soares, E Bonfá, FL Neto Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (3), 695-700, 2008 | 124 | 2008 |
| Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases CGS Saad, EF Borba, NE Aikawa, CA Silva, RMR Pereira, AL Calich, ... Annals of the rheumatic diseases 70 (6), 1068-1073, 2011 | 115 | 2011 |
| Systemic lupus erythematosus and “lupus dyslipoproteinemia” JF de Carvalho, E Bonfá, EF Borba Autoimmunity reviews 7 (3), 246-250, 2008 | 114 | 2008 |
| Mechanisms of dyslipoproteinemias in systemic lupus erythematosus EF Borba, JF Carvalho, E Bonfá Journal of Immunology Research 13, 203-208, 2006 | 111 | 2006 |
| The role of inflammation, humoral and cell mediated autoimmunity in the pathogenesis of atherosclerosis P Alves, B Ferreira Swiss Medical Weekly 138 (3738), 534-539, 2008 | 104 | 2008 |
| Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases JA Gómez-Puerta, R Cervera, G Espinosa, RA Asherson, ... Annals of the rheumatic diseases 66 (6), 740-746, 2007 | 101 | 2007 |
